Eli Lilly and Company
The role involves conducting research on protein and peptide therapeutics, focusing on formulation strategies and mechanistic modeling to support the development of next‑generation biological drug products. The scientist will apply biophysical and analytical techniques, collaborate with cross‑functional teams, and contribute to scientific publications and presentations.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
26% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Sr. Scientist, Analytical R&D
MSD
Principal Scientist – Protein Formulation & Biophysical Characterization (High-Concentration Biologics)
Pfizer
Postdoctoral Research Fellow – Quantitative Biosciences Early Discovery
Merck & Co., Inc.
Post-Doctoral Fellow
The Wistar Institute
Principal Scientist
GSK plc
Postdoctoral Research Fellow – Quantitative Biosciences Early Discovery
Merck & Co., Inc.